Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Optellum logo — Early lung cancer diagnosis with AI

Optellum

Early lung cancer diagnosis with AI

Founded 2016 United Kingdom Oxford, United Kingdom 49 employees Series A Total: $15.05M Health Care, Medical Devices +1

General Information

Company Name Optellum
Founded Year 2016
Location United Kingdom Oxford, United Kingdom +1
Founders / Decision Makers
Team member
Employees 49
Industries Health Care, Medical Devices, Machine Learning
Funding Stage Series A
Social

Get notified when Optellum moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Optellum

Optellum, a UK-based startup, is revolutionizing early diagnosis and treatment of lung cancer using Artificial Intelligence and Machine Learning. The company's mission is to ensure that every lung cancer patient receives the most effective treatment at the earliest possible stage. Their pioneering Clinical Decision Support software, developed by a team of experts from Oxford's computer vision laboratory, analyzes the world's largest clinical dataset to provide personalized diagnosis and treatment recommendations. With a track record of successful innovation and the backing of a renowned Advisory Board, Optellum secured a significant $14.00M Series A investment from a group of esteemed investors including IQ Capital, Black Opal Ventures, Intuitive, Sir Martin & Lady Audrey Wood, Mercia Fund Managers, and St John's College - Oxford, in September 2022. The company's focus on assembling a high-caliber development team, comprising former engineers from leading technology companies and imaging startup veterans, underscores its commitment to the fight against cancer. For further details, visit http://www.optellum.com/.

Taxonomy: medical diagnostics, digital health, cancer, deep learning, big data, patient stratification, medical imaging, lung cancer, early diagnosis, treatment, oncology

Services & Products

AI-powered lung cancer diagnosis and precision care platform

Target Customers

healthcare providers healthcare professionals hospitals health systems

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Series A •••••• 6
Investor Investor Investor
•••• •••• 		27 Sep 2022
Seed Round •••••• 3
Investor Investor
•••• •••• 		16 Jul 2019
Grant •••••• 1 •••• •••• 01 Apr 2016

Optellum Alternatives & Competitors

Optellum vs
Neura Health
Neura Health United States

Neura Health is Digital Health Startup working on making Medical Imaging AI more accessible to Healt...

1 employees
AI, Health Care
Optellum vs
bioAffinity Technologies
bioAffinity Technologies United States

Addressing a critical need to find cancer early and treat cancer at the cellular level.

Post Ipo Equity
22 employees
Biotechnology, Health Care
Compare Optellum vs bioAffinity Technologies
Optellum vs
Grid Therapeutics
Grid Therapeutics United States

Grid Therapeutics is a biotech company based on the innovative science first developed by Edward F....

Series B
4 employees
Biotechnology, Life Sciences
Compare Optellum vs Grid Therapeutics
Also compare with: Optellum vs Hera-MI Hera-MI

FAQ About Optellum

Early lung cancer diagnosis with AI
Optellum was founded in 2016.
Optellum is headquartered in Oxford, United Kingdom.
Optellum operates in the following industries: Health Care, Medical Devices, Machine Learning.
Optellum has approximately 49 employees.
Optellum has completed 3 funding rounds, raising a total of $15.05M. The latest funding stage is Series A.
Optellum offers: AI-powered lung cancer diagnosis and precision care platform.
Top alternatives and competitors to Optellum include Neura Health , bioAffinity Technologies, Grid Therapeutics, Hera-MI, Addario Lung Cancer Medical Institute (ALCMI) . These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Optellum and Neura Health are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Optellum and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy